J.P. Bercu
Advertisement
J.P. Bercu is senior director in nonclinical safety and pathobiology, Gilead Sciences.
Articles by J.P. Bercu
Advertisement
Latest Updated Articles
Managing the Risk of Nitrosamine ImpuritiesMarch 15th 2021
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Approves Pfizer’s Breast Cancer Treatment
2
Orally Dissolving Films: A Modern Solution for Convenient Drug Delivery
3
Writing the Biological Script: Scaling DNA Manufacturing for the Next Generation of Therapeutics
4
Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value
5